BioSpace News Archive

UniPath, a Colorado-based provider of subspecialty pathology, clinical and molecular testing services, is now offering COVID-19 testing to employers anxious to safely get their workers back on the job.

CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today highlighted that ImmunityBio and NantKwest announced the initiation of a Phase 2 randomized, two-cohort, open-label study for first and second-line treatment of locally advanced or metastatic pancreatic cancer (QUILT-88).

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Sapphire Biotech, Inc.

OncoSec Medical Incorporated (the “Company” or “OncoSec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that it will present new pre-clinical data demonstrating the utility of OncoSec’s next-generation product candidate, TAVO PLUS (enhanced interleukin-12 or “IL

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) is working with the FDA Sentinel Operations Center at the Har

FUJIFILM Medical Systems U.S.A. Inc ., a leading provider of enterprise imaging and informatics solutions, and part of the greater Fujifilm Healthcare portfolio, today announced that three more diagno

Activ Surgical, a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patients outcomes and accessibility, today announced the appointment of Subhrangshu (Sub) Datta as Chief Operating Officer (COO)

The solution will be used to soften social distancing, restore public confidence in the workplace and care for people in homes.

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus’ total funding n

R.R. Donnelley & Sons Company (RRD) (NYSE: RRD), a leading global provider of multichannel solutions for marketing and business communications, today introduced an integrated, comprehensive product launch solution for pharmaceutical companies that accelerates the time-to-market for life-saving drugs while overcoming the challenges of a highly regulated industry.